| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.85B | 2.79B | 2.69B | 2.63B | 2.59B | 2.36B |
| Gross Profit | 1.57B | 1.54B | 1.49B | 1.43B | 1.43B | 1.32B |
| EBITDA | 913.91M | 874.79M | 810.58M | 786.74M | 771.62M | 703.55M |
| Net Income | 523.20M | 484.47M | 467.28M | 487.49M | 513.10M | 454.37M |
Balance Sheet | ||||||
| Total Assets | 5.96B | 5.92B | 6.00B | 5.25B | 3.82B | 3.79B |
| Cash, Cash Equivalents and Short-Term Investments | 120.39M | 108.44M | 115.95M | 115.68M | 163.46M | 299.97M |
| Total Debt | 2.14B | 2.16B | 2.40B | 1.96B | 951.22M | 1.05B |
| Total Liabilities | 2.85B | 2.87B | 3.07B | 2.65B | 1.53B | 1.63B |
| Stockholders Equity | 3.11B | 3.04B | 2.93B | 2.60B | 2.29B | 2.16B |
Cash Flow | ||||||
| Free Cash Flow | 646.31M | 661.12M | 491.78M | 606.70M | 461.70M | 507.62M |
| Operating Cash Flow | 700.48M | 719.17M | 556.19M | 641.28M | 513.13M | 545.93M |
| Investing Cash Flow | -30.09M | -26.69M | -844.40M | -1.44B | -222.76M | -33.17M |
| Financing Cash Flow | -691.09M | -706.43M | 294.50M | 750.51M | -416.01M | -422.91M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $15.46B | 30.31 | 19.92% | 1.32% | 2.85% | 3.09% | |
78 Outperform | $17.81B | 33.88 | 17.85% | 0.79% | 8.01% | 2.67% | |
77 Outperform | $15.50B | 32.48 | 12.35% | 1.56% | 7.09% | -2.29% | |
76 Outperform | $16.45B | 31.86 | 17.47% | 1.64% | 3.78% | 4.85% | |
65 Neutral | $11.77B | 32.65 | 17.92% | 0.49% | -0.37% | 21.77% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | $13.80B | 88.04 | 6.22% | ― | 5.52% | 9.03% |
Nordson Corporation reported record first-quarter fiscal 2026 results on February 18, 2026, with sales rising 9% year over year to $669 million, driven by 7% organic growth and favorable currency, and net income climbing to $133 million, or $2.38 per diluted share. Adjusted earnings per share reached a first-quarter record of $2.37, backlog increased about 4%, all segments delivered organic growth led by Advanced Technology Solutions’ 23% sales gain, and management raised both second-quarter and full-year 2026 sales and adjusted earnings guidance, signaling growing confidence in demand, particularly in semiconductor and electronics end markets.
The most recent analyst rating on (NDSN) stock is a Buy with a $312.00 price target. To see the full list of analyst forecasts on Nordson stock, see the NDSN Stock Forecast page.
On January 30, 2026, Nordson Corporation entered into an amended and restated senior unsecured multicurrency revolving credit agreement, replacing its June 6, 2023 facility and establishing a $1.2 billion revolving credit line maturing on January 30, 2031. The agreement, arranged with Wells Fargo as administrative agent and a syndicate of global lenders, allows borrowings in multiple major currencies, includes sub-facilities for standby letters of credit and swingline loans, and is governed by customary covenants tied to leverage and interest coverage ratios, as well as standard events of default. Interest rates under the facility are indexed to base or benchmark rates such as SOFR, EURIBOR, TIBOR, SORA, SONIA or SARON plus a margin based on Nordson’s leverage or debt rating, with proceeds available for working capital, acquisitions, and general corporate purposes, including refinancing existing debt. At closing, Nordson used part of the new facility to repay and retire $248 million of outstanding term loans under its prior credit arrangement, enhancing its financial flexibility and extending its debt maturity profile.
The most recent analyst rating on (NDSN) stock is a Buy with a $311.00 price target. To see the full list of analyst forecasts on Nordson stock, see the NDSN Stock Forecast page.
Nordson Corporation reported record results for the fourth quarter and fiscal year 2025, with sales reaching $752 million in the fourth quarter and $2.8 billion for the full year, marking a 1% and 4% increase respectively over the prior year. The company achieved a 9% increase in adjusted earnings per share for the fourth quarter and a 5% increase for the full year, reflecting strong operational performance despite challenges such as the divestiture of its medical contract manufacturing business. Looking ahead to fiscal 2026, Nordson forecasts sales between $2,830 to $2,950 million and adjusted earnings per share ranging from $10.80 to $11.50, driven by its strategic growth framework and strong backlog.
The most recent analyst rating on (NDSN) stock is a Buy with a $285.00 price target. To see the full list of analyst forecasts on Nordson stock, see the NDSN Stock Forecast page.